# NHS Midlands & East Framework for Denosumab 60mg PFS

Project title: NHS Midlands & East Framework for Denosumab 60mg PFS Offer reference number: CM/TNS/26/5768 Period of framework: 01 January 2027 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 16 month…

Source: QUOTA CÔTE — https://quotacote.com/opportunites/nhs-midlands-east-framework-for-denosumab-60mg-pfs-royaume-uni--3e6e70b0-f1ec-43eb-80fd-5863c48552b8
Last checked by QUOTA: 2026-09-18
Methodology: https://quotacote.com/a-propos-des-donnees

## Key facts

- Country: Royaume-Uni [FACT]
- Deadline: 2026-10-13 [FACT]
- Last checked by QUOTA: 2026-09-18 [FACT]
- Sector (QUOTA normalisation): Santé [ANALYSIS]
- Summary: QUOTA editorial summary of the source notice [ANALYSIS]

## Entities

- geography: Royaume-Uni
- funder: NHS England
- buyer: NHS England

## Limitations

- QUOTA republishes a normalised summary, not the tender documents themselves.
- Commercial details (source dossier, full deadline history, budget) are reserved for subscribers.